期刊文献+

卵巢肿瘤组织中血管内皮生长因子及其受体表达与临床病理的关系 被引量:2

Relationship between the Vascular Endothelial Growth Factor and Receptors of Ovarian Neoplasm and Its Clinic Pathology
在线阅读 下载PDF
导出
摘要 目的:探讨卵巢肿瘤组织中VEGF表达及其受体与临床病理的关系。方法:对54例卵巢恶性肿瘤、14例卵巢良性肿瘤和16例正常卵巢组织采用免疫组织化学方法测定其VEGF及受体蛋白表达,并分析与临床病理的关系。结果:1)恶性肿瘤组织中VEGF及其受体蛋白表达阳性率明显高于良性肿瘤和正常卵巢组织,均有显著性差异(P<0.01)。2)恶性肿瘤内的VEGF表达阳性率与临床分期无明显相关(P>0.05)。但VEGF受体蛋白表达阳性率在晚期患者组织中明显高于早期患者(P<0.05)。3)VEGF受体表达阳性与其患者的腹水量、大网膜转移和盆腹腔淋巴结转移阳性呈正相关(P<0.05)。4)恶性肿瘤组织中VEGF及其受体蛋白共表达阳性者的平均总生存期明显低于不表达者。Kaplan-Meier生存曲线分析显示,二者累积生存率有显著性差异(P<0.05)。结论:恶性肿瘤组织中的VEGF及其受体蛋白阳性表达明显增高,其受体表达与患者的临床分期、腹水量、大网膜和盆腹腔淋巴结转移相关,VEGF及其受体蛋白共表达为卵巢癌患者的不良预后。 Objective:To explore the relationship between vascular endothelial growth fac-tor(VEGF)as well as receptors of ovarian neoplasm and it’s clinic-pathology.Methods :Strepta-vidin-Peroxidase immunohistochemistry method was used to determine the expression of VEGF and VEGF-receptors in54cases of ovarian malignant 、14cases of ovarian benign neoplasm and16cases of normal control.Results:(1)The expression of VEGF and receptors in ovarian malig nant was higher than that in ovarian benign neoplasm and normal control(P<0.01).(2)The expression of VEGF-receptor in patients with late stage was higher than that in early stage(P<0.05).(3)VEGF-receptors was observed more frequently in patients with large amount of ascitic volume 、o-mentum and lymph node metastasis(P<0.05).(4)The average survival in The expression of VEGF and receptors positive patients was less than that in the expression of VEGF and receptors nega-tive,Kaplan-Meier survival curve showed that there was significantly difference between the ex-pression of VEGF and receptors positive and negative patients.Conclusion:The expression of VEGF and receptors in ovarian malignant was higher.VEGF-receptor was related with large amount of ascitic volume of patient with ovarian carcinomas.The co-expression of VEGF and its receptor had a poorly overall survive in ovarian cancer patients.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第7期466-469,共4页 Chinese Journal of Clinical Oncology
基金 广西壮族自治区自然科学基金资助(桂科回009009)
关键词 卵巢肿瘤 血管内皮生长因子 血管内皮生长因子受体 预后 Ovarian malignant Vascular endothelial growth factor(VEGF)VEGF-receptor Prognoses
  • 相关文献

参考文献10

  • 1[1]Ferrara N. Molecular and biological properties of vascular endothelial growth factor[J]. J Mol Med, 1999, 77(7):527~534
  • 2[2]Gerber HP, Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis[J]. J Mol Med, 2003, 81(1):20~31
  • 3[3]Abulafia O, Triest WE, Sherer DM. Angiogenesis in malignancies of the female genital tract[J]. Gynecol Oncol, 1999, 72(2):220~231
  • 4[4]Fujimoto J, Sakaguchi H, Hirose R, et al. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma[J]. Cancer 1998, 83(12):2528~2533
  • 5[5]Boocock CA, Charnock-Jones DS, Sharkey AM, et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma [J]. J Natl Cancer Inst,1995, 87(7):506~516
  • 6[6]Fujimoto J, Sakaguchi H, Aoki I, et al. Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers[J]. Br J Cancer, 2001, 85(3):313~316
  • 7[7]Shibuya M, Luo JC, Toyoda M. Involvement of VEGF and its receptors in ascites tumor formation[J]. Cancer Chemother Pharmacol, 1999, 43(Suppl):72~77
  • 8[8]Obermair A, Wasicky R, Kaider A, et al. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer [J].Cancer Lett, 1999,138(1-2):175~182
  • 9[9]Yokoyama Y, Charnock-Jones DS, Licence D, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma[J]. BJC, 2003, 88(3):237~244
  • 10[10]Gasparini G, Bonoldi E, Viale G, et al. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas [J].Int J Cancer, 1996, 69(3):205~211

同被引文献13

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部